Assenagon Asset Management S.A. increased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 39.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,455,402 shares of the semiconductor company's stock after purchasing an additional 695,146 shares during the period. Synopsys makes up 1.4% of Assenagon Asset Management S.A.'s investment portfolio, making the stock its 12th largest holding. Assenagon Asset Management S.A. owned about 1.28% of Synopsys worth $1,095,281,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Brighton Jones LLC increased its position in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock worth $447,000 after acquiring an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC increased its holdings in Synopsys by 11.6% during the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock worth $326,000 after purchasing an additional 79 shares in the last quarter. NewEdge Advisors LLC raised its stake in shares of Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock worth $1,291,000 after purchasing an additional 395 shares during the last quarter. WINTON GROUP Ltd lifted its holdings in shares of Synopsys by 9.2% in the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock valued at $389,000 after purchasing an additional 64 shares in the last quarter. Finally, Treasurer of the State of North Carolina lifted its holdings in shares of Synopsys by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company's stock valued at $36,962,000 after purchasing an additional 1,505 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently issued reports on SNPS shares. Bank of America upped their price target on Synopsys from $515.00 to $600.00 and gave the stock a "buy" rating in a report on Thursday, May 28th. Benchmark began coverage on shares of Synopsys in a report on Wednesday, July 15th. They issued a "buy" rating and a $570.00 target price for the company. Citigroup raised their price target on shares of Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, May 28th. BNP Paribas Exane upped their price objective on shares of Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research report on Thursday, May 28th. Finally, KeyCorp reiterated an "overweight" rating on shares of Synopsys in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $570.06.
Check Out Our Latest Stock Report on Synopsys
Insider Buying and Selling at Synopsys
In related news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company's stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company's stock.
Synopsys Price Performance
SNPS opened at $405.98 on Friday. The firm has a market cap of $77.74 billion, a P/E ratio of 93.98, a PEG ratio of 2.35 and a beta of 1.23. The firm has a 50-day moving average of $434.62 and a 200 day moving average of $447.00. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $632.99.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the firm posted $3.67 earnings per share. The company's revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.65 EPS for the current year.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.